TABLE 3.
Plasma concentration of pirarubicin (ng/ml) in the weekly US-assisted intravesical chemotherapy.
| 1st | 2nd | 3rd | 4th | 5th | 6th | 7th | 8th | 9th | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Before | Dog 4 | <0.5 | <0.5 | <0.5 | <0.5 | <0.5 | <0.5 | <0.5 | <0.5 | <0.5 |
| Dog 5 | <0.5 | <0.5 | <0.5 | <0.5 | <0.5 | <0.5 | <0.5 | <0.5 | <0.5 | |
| Dog 6 | <0.5 | <0.5 | <0.5 | <0.5 | <0.5 | <0.5 | <0.5 | <0.5 | <0.5 | |
| After 30 min | Dog 4 | <0.5 | <0.5 | <0.5 | <0.5 | <0.5 | <0.5 | <0.5 | <0.5 | <0.5 |
| Dog 5 | <0.5 | <0.5 | <0.5 | <0.5 | <0.5 | <0.5 | <0.5 | <0.5 | <0.5 | |
| Dog 6 | <0.5 | <0.5 | <0.5 | <0.5 | <0.5 | <0.5 | <0.5 | <0.5 | <0.5 |